- Home
- ETON vs RVSB Comparison
ETON vs RVSB Comparison
Compare ETON & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- RVSB
- Stock Information
- Founded
- ETON 2017
- RVSB 1923
- Country
- ETON United States
- RVSB United States
- Employees
- ETON N/A
- RVSB N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- RVSB Savings Institutions
- Sector
- ETON Health Care
- RVSB Finance
- Exchange
- ETON Nasdaq
- RVSB Nasdaq
- Market Cap
- ETON 388.3M
- RVSB 115.6M
- IPO Year
- ETON 2018
- RVSB 1993
- Fundamental
- Price
- ETON $14.85
- RVSB $5.69
- Analyst Decision
- ETON Strong Buy
- RVSB Buy
- Analyst Count
- ETON 3
- RVSB 1
- Target Price
- ETON $29.67
- RVSB $7.00
- AVG Volume (30 Days)
- ETON 621.3K
- RVSB 253.4K
- Earning Date
- ETON 08-07-2025
- RVSB 07-24-2025
- Dividend Yield
- ETON N/A
- RVSB 1.40%
- EPS Growth
- ETON N/A
- RVSB 27.97
- EPS
- ETON N/A
- RVSB 0.23
- Revenue
- ETON $48,327,000.00
- RVSB $50,239,000.00
- Revenue This Year
- ETON $103.21
- RVSB $12.68
- Revenue Next Year
- ETON $51.34
- RVSB $11.53
- P/E Ratio
- ETON N/A
- RVSB $24.78
- Revenue Growth
- ETON 40.88
- RVSB 3.95
- 52 Week Low
- ETON $3.25
- RVSB $3.68
- 52 Week High
- ETON $21.48
- RVSB $6.59
- Technical
- Relative Strength Index (RSI)
- ETON 54.31
- RVSB 57.09
- Support Level
- ETON $13.78
- RVSB $5.65
- Resistance Level
- ETON $16.27
- RVSB $5.85
- Average True Range (ATR)
- ETON 0.83
- RVSB 0.14
- MACD
- ETON 0.32
- RVSB 0.04
- Stochastic Oscillator
- ETON 77.67
- RVSB 71.15
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.